Status and phase
Conditions
Treatments
About
The primary objective of this study is to determine if trandolapril/verapamil (Tarka®) is superior to amlodipine/benazepril (Lotrel®) in reduction of albuminuria in hypertensive subjects with Type 2 diabetes mellitus (DM) and diabetic nephropathy
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Type 1 DM.
Subject has severe hepatic dysfunction at Screening as determined by liver function tests:
Subject has non-diabetic renal disease.
Subject has a hypersensitivity to ACE inhibitor, CCB, torsemide or sulfonylureas.
Primary purpose
Allocation
Interventional model
Masking
357 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal